Bénéfice Avant Impôts Changement Date
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Cipla INR 7.49B 4.2B 2026-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -7.66M 64.51M 2026-03
CSL USD 2.61B 1.21B 2025-12
Enanta Pharmaceuticals USD -22.71M 95.08M 2024-12
Grifols EUR 257.85M 190.87M 2024-12
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -162.1M 164.84M 2026-03
Omeros USD -65.12M 21.27M 2024-06
OraSure Technologies USD -18.43M 5.14M 2025-12
Quidel USD -79.5M 32.9M 2026-03
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
United Therapeutics USD 444M 6M 2025-12
Xoma USD 15.98M 24.58M 2024-06